High-quality clinical trials require significant and sustained financial investment to deliver real-world results. As a not-for-profit organisation, Melanoma and Skin Cancer Trials cannot rely on government funding alone. We need your help to improve the lives of melanoma and skin cancer patients.
Our clinical trials are answering the many research questions emerging from the introduction of combined cancer treatment methods, such as our GoTHAM and CHARLI clinical trials.
Our clinical trials also explore how to improve diagnosis and how to prevent melanoma and skin cancer from reoccurring, such as our IMAGE trial and SiroSkin trials.
Surgical intervention – once the only option for melanoma and skin cancer patients – is now being refined through our world-wide MelMarT-II trial that will reduce the potential for disfigurement for patients and the burden on the healthcare system.